C9orf72

Item Information
Catalog #
Size
Price
Description

The protein encoded by this gene plays an important role in the regulation of endosomal trafficking, and has been shown to interact with Rab proteins that are involved in autophagy and endocytic transport. Expansion of a GGGGCC repeat from 2-22 copies to 700-1600 copies in the intronic sequence between alternate 5' exons in transcripts from this gene is associated with 9p-linked ALS (amyotrophic lateral sclerosis) and FTD (frontotemporal dementia) (PMID: 21944778, 21944779). Studies suggest that hexanucleotide expansions could result in the selective stabilization of repeat-containing pre-mRNA, and the accumulation of insoluble dipeptide repeat protein aggregates that could be pathogenic in FTD-ALS patients (PMID: 23393093). Alternative splicing results in multiple transcript variants encoding different isoforms.

Product Overview
Entrez GenelD
203228
Aliases
ALSFTD; DENND9; FTDALS; DENNL72; FTDALS1
Clone#
6D6F12
Host / Isotype
Mouse / Mouse IgG2b
Species Reactivity
Human, Mouse, Monkey, Rat
Immunogen
Purified recombinant fragment of human C9orf72 (AA: 110-199) expressed in E. Coli.
Formulation
Purified antibody in PBS with 0.05% sodium azide
Storage
4℃; -20℃ for long term storage
Product Applications
WB (Western Blot)
1/500 - 1/2000
IHC_P(Immunohistochemistry)
1/200 - 1/1000
ICC (Immunocytochemistry)
1/200 - 1/1000
FCM (Flow Cytometry)
1/200 - 1/400
ELISA
1/10000
References
1.Sci Rep. 2021 Dec 1;11(1):23213.
2.RNA. 2022 Feb;28(2):123-138.
Product Image
Elisa
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)
Western Blot
Figure 2:Western blot analysis using C9orf72 mAb against human C9orf72 (AA: 110-199) recombinant protein. (Expected MW is 24 kDa)
Figure 2:Western blot analysis using C9orf72 mAb against human C9orf72 (AA: 110-199) recombinant protein. (Expected MW is 24 kDa)
Western Blot
Figure 3:Western blot analysis using C9orf72 mAb against HEK293-6e (1) and C9orf72 (AA: 110-199)-hIgGFc transfected HEK293-6e (2) cell lysate.
Figure 3:Western blot analysis using C9orf72 mAb against HEK293-6e (1) and C9orf72 (AA: 110-199)-hIgGFc transfected HEK293-6e (2) cell lysate.
Western Blot
Figure 4:Western blot analysis using C9orf72 mouse mAb against C6 (1), PC-12 (2),COS-7 (3),NIH/3T3 (4) and SK-N-SH (5) cell lysate.
Figure 4:Western blot analysis using C9orf72 mouse mAb against C6 (1), PC-12 (2),COS-7 (3),NIH/3T3 (4) and SK-N-SH (5) cell lysate.
Immunohistochemical analysis
Figure 5:Immunofluorescence analysis of Hela cells using C9orf72 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin. Secondary antibody from Fisher (Cat#: 35503)
Figure 5:Immunofluorescence analysis of Hela cells using C9orf72 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin. Secondary antibody from Fisher (Cat#: 35503)
Immunofluorescence analysis
Figure 6:Flow cytometric analysis of Hela cells using C9orf72 mouse mAb (green) and negative control (red).
Figure 6:Flow cytometric analysis of Hela cells using C9orf72 mouse mAb (green) and negative control (red).
Immunohistochemical analysis
Figure 7:Immunohistochemical analysis of paraffin-embedded bladder cancer tissues using C9orf72 mouse mAb with DAB staining.
Figure 7:Immunohistochemical analysis of paraffin-embedded bladder cancer tissues using C9orf72 mouse mAb with DAB staining.
Immunohistochemical analysis
Figure 8:Immunohistochemical analysis of paraffin-embedded breast cancer tissues using C9orf72 mouse mAb with DAB staining.
Figure 8:Immunohistochemical analysis of paraffin-embedded breast cancer tissues using C9orf72 mouse mAb with DAB staining.
Immunohistochemical analysis
Figure 9:Immunohistochemical analysis of paraffin-embedded mouse spleen tissues using C9orf72 mouse mAb with DAB staining.
Figure 9:Immunohistochemical analysis of paraffin-embedded mouse spleen tissues using C9orf72 mouse mAb with DAB staining.
Immunohistochemical analysis
Figure 10:Immunohistochemical analysis of paraffin-embedded mouse kidney tissues using C9orf72 mouse mAb with DAB staining.
Figure 10:Immunohistochemical analysis of paraffin-embedded mouse kidney tissues using C9orf72 mouse mAb with DAB staining.
Immunohistochemical analysis
Figure 11:Immunohistochemical analysis of paraffin-embedded rat spleen tissues using C9orf72 mouse mAb with DAB staining.
Figure 11:Immunohistochemical analysis of paraffin-embedded rat spleen tissues using C9orf72 mouse mAb with DAB staining.
Immunohistochemical analysis
Figure 13:Immunohistochemical analysis of paraffin-embedded rabbit spleen tissues using C9orf72 mouse mAb with DAB staining.
Figure 13:Immunohistochemical analysis of paraffin-embedded rabbit spleen tissues using C9orf72 mouse mAb with DAB staining.
Immunohistochemical analysis
Figure 14:Immunohistochemical analysis of paraffin-embedded rat kidney tissues using C9orf72 mouse mAb with DAB staining.
Figure 14:Immunohistochemical analysis of paraffin-embedded rat kidney tissues using C9orf72 mouse mAb with DAB staining.
Immunohistochemical analysis
Figure 14:Immunohistochemical analysis of paraffin-embedded rabbit kidney tissues using C9orf72 mouse mAb with DAB staining.
Figure 14:Immunohistochemical analysis of paraffin-embedded rabbit kidney tissues using C9orf72 mouse mAb with DAB staining.
For Research Use Only. Not for use in diagnostic procedures.